Addition of Lenalidomide to R‐chop (r2chop) Improves Outcomes in Newly Diagnosed Diffuse Large B‐cell Lymphoma (dlbcl): First Report of Ecog‐acrin1412 a Randomized Phase 2 Us Intergroup Study of R2chop Vs R‐chop
Year: 2019
Type: article
Source: Hematological Oncology
DOI: 10.1002/hon.6_2629
Institutions: Mayo Clinic, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, BC Cancer Agency, Johns Hopkins University, University of Rochester, Trinity Health Ann Arbor Hospital, Winship Cancer Institute, Columbia University Irving Medical Center, Weill Cornell Medicine, National Institutes of Health, National Cancer Institute, Mount Sinai Hospital, Washington University in St. Louis, Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2952129287